Showing results (101-110 of 198) with videos related to
Sort By:
Pageof 20
JCI Insight|February 15, 2024
Single-cell analyses of metastatic bone marrow in human neuroblastoma reveals microenvironmental remodeling and metastatic signatureShenglin Mei, Adele M Alchahin, Bethel Tesfai Embaie, et al.International Journal of Oncology|February 23, 2008
Analysis of neuroblastoma tumour progression; loss of PHOX2B on 4p13 and 17q gain are early events in neuroblastoma tumourigenesisCecilia Krona, Helena Carén, Rose-Marie Sjöberg, et al.International Journal of Molecular Sciences|April 12, 2022
The Merkel Cell Polyomavirus T-Antigens and IL-33/ST2-IL1RAcP Axis: Possible Role in Merkel Cell CarcinomaKashif Rasheed, Ugo Moens, Benedetta Policastro, et al.Oncoimmunology|June 27, 2013
The microenvironment of human neuroblastoma supports the activation of tumor-associated T lymphocytesLena-Maria Carlson, Anna De Geer, Baldur Sveinbjørnsson, et al.The EMBO Journal|November 11, 2024
METTL3/MYCN cooperation drives neural crest differentiation and provides therapeutic vulnerability in neuroblastomaKetan Thombare, Roshan Vaid, Perla Pucci, et al.International Journal of Cancer|July 8, 2010
Birth characteristics and Wilms tumors in children in the Nordic countries: a register-based case-control studyJoachim Schüz, Lisbeth Samsø Schmidt, Per Kogner, et al.Anticancer Research|August 8, 2009
The angiogenic growth factors HGF and VEGF in serum and plasma from neuroblastoma patientsErik G Sköldenberg, Anders Larsson, Ake Jakobson, et al.Carcinogenesis|January 26, 2013
Low-dose aspirin delays an inflammatory tumor progression in vivo in a transgenic mouse model of neuroblastomaLena-Maria Carlson, Agnes Rasmuson, Helena Idborg, et al.Molecular Cancer|August 31, 2024
Joint single-cell genetic and transcriptomic analysis reveal pre-malignant SCP-like subclones in human neuroblastomaThale K Olsen, Jörg Otte, Shenglin Mei, et al.Journal of the National Cancer Institute|March 4, 2014
Protective role of humanin on bortezomib-induced bone growth impairment in anticancer treatmentEmma Eriksson, Malin Wickström, Lova Segerström Perup, et al.Pageof 20